QRICH1 Drives HBV-Related HMGB1 Secretion and Hepatic Fibrosis

Study Background and Research Question

Chronic hepatitis B virus (HBV) infection is a major global health concern, often resulting in progressive liver fibrosis and, ultimately, hepatocellular carcinoma. A pivotal mediator in the inflammatory cascade of liver injury is high mobility group box 1 (HMGB1), a nuclear protein that acts as a damage-associated molecular pattern (DAMP) when released extracellularly. HMGB1 secretion is associated with exacerbation of liver inflammation and fibrosis, but the molecular mechanisms governing its release during HBV infection remain incompletely understood. Endoplasmic reticulum (ER) stress is increasingly recognized as a driver of hepatic fibrosis, yet the precise effectors linking ER stress to HMGB1 secretion in the context of HBV are not fully characterized. This study by Feng et al. addresses whether QRICH1, a glutamine-rich protein upregulated during ER stress, modulates HMGB1 secretion and contributes to HBV-induced hepatic fibrosis [source_type: paper][source_link: https://doi.org/10.1016/j.imbio.2025.152913].

Key Innovation from the Reference Study

The central innovation of this work is the identification of QRICH1 as a key effector that amplifies HBV-driven HMGB1 translocation and secretion in hepatocytes. Specifically, the study demonstrates that QRICH1 expression, elevated under ER stress, enhances the transcription and cytoplasmic translocation of HMGB1. This mechanistic link between ER stress, QRICH1 induction, and HMGB1 secretion delineates a novel pathway by which HBV infection exacerbates liver fibrosis, moving beyond previous models that focused primarily on direct viral effects or global ER stress responses [source_type: paper][source_link: https://doi.org/10.1016/j.imbio.2025.152913].

Methods and Experimental Design Insights

The study utilized a combination of in vivo and ex vivo approaches to dissect the mechanistic relationship between QRICH1, ER stress, and HMGB1 secretion:

• Animal models: Chronic recombinant covalently closed circular DNA (rcccDNA) mouse models were used to simulate persistent HBV infection and hepatic fibrosis. These models are well-established for recapitulating chronic viral hepatitis and fibrogenesis [source_type: paper][source_link: https://doi.org/10.1016/j.imbio.2025.152913].
• Clinical specimens: Liver biopsy samples from patients with chronic hepatitis B and various degrees of fibrosis were analyzed, enhancing the translational relevance of the findings.
• Histological and immunochemical analyses: Liver collagen deposition was evaluated via Sirius red and Masson’s trichrome staining, while QRICH1 and HMGB1 expression were assessed by immunohistochemistry.
• Molecular assays: Cytoplasmic and nuclear HMGB1 localization was quantified by Western blotting and qRT-PCR. Serum HMGB1 and liver injury markers were measured using ELISA.
• Mechanistic interrogation: The study also examined the role of SIRT6, a deacetylase modulated by HBV, in regulating HMGB1 acetylation and translocation.

Protocol Parameters

• assay | Sirius red staining | paraffin-embedded liver sections | Quantification of collagen deposition in hepatic fibrosis | paper | https://doi.org/10.1016/j.imbio.2025.152913
• assay | ELISA | mouse serum or patient plasma | Measurement of HMGB1 concentration as a fibrosis biomarker | paper | https://doi.org/10.1016/j.imbio.2025.152913
• assay | Immunohistochemistry | liver tissue sections | Detection and localization of QRICH1 and HMGB1 proteins | paper | https://doi.org/10.1016/j.imbio.2025.152913
• assay | Western blotting | subcellular fractions | Analysis of HMGB1 cyto-translocation (nuclear vs. cytoplasmic) | paper | https://doi.org/10.1016/j.imbio.2025.152913
• compound handling | Tetracycline | ≥74.9 mg/mL in DMSO | For use as an antibiotic selection marker or ribosomal function probe | product_spec | https://www.apexbt.com/tetracycline.html
• storage | Tetracycline | -20°C | Preserves compound integrity; avoid long-term storage of solutions | product_spec | https://www.apexbt.com/tetracycline.html

Core Findings and Why They Matter

The principal findings of the study are as follows:

• ER stress aggravates HBV-induced hepatic fibrosis: Mice exposed to both HBV and ER stress inducers developed more severe fibrosis, with increased HMGB1 secretion and collagen deposition [source_type: paper][source_link: https://doi.org/10.1016/j.imbio.2025.152913].
• QRICH1 is upregulated in fibrotic livers: Both mouse models and patient samples with advanced fibrosis showed higher levels of QRICH1, which positively correlated with HMGB1 expression.
• QRICH1 drives HMGB1 translocation and secretion: Mechanistic experiments revealed that QRICH1 enhances HMGB1 transcription and promotes its acetylation—via modulation of SIRT6—leading to nuclear export and extracellular release.
• SIRT6 regulation by HBV: HBV infection downregulates SIRT6 expression, increasing acetylation-dependent HMGB1 translocation.

By elucidating this axis, the study provides a molecular rationale for targeting ER stress signaling and QRICH1 in therapeutic strategies for HBV-induced hepatic fibrosis.

Comparison with Existing Internal Articles

Recent internal resources have highlighted the versatility of tetracycline, a broad-spectrum polyketide antibiotic, in dissecting cellular stress pathways and ribosomal dynamics. For instance, "Tetracycline in Cellular Stress Pathways" and "Tetracycline in Advanced Ribosomal and ER Stress Research" both discuss the use of tetracycline as a tool for studying inhibition of bacterial protein synthesis and as a probe for ribosomal function research. These articles emphasize the compound’s utility in modeling cellular stress and monitoring protein synthesis, which are conceptually related to the current study's focus on ER stress and protein trafficking. However, the reference paper advances the field by connecting ER stress effectors (QRICH1) to viral modulation of host protein secretion, a pathway not explicitly covered in the internal resources.

Limitations and Transferability

While the study offers compelling evidence for QRICH1's role in HBV-induced hepatic fibrosis, several limitations should be considered:

• Translational scope: The mechanistic findings are robust in murine models and supported by patient biopsy data, but further validation in larger, diverse human cohorts is necessary before direct clinical translation [source_type: paper][source_link: https://doi.org/10.1016/j.imbio.2025.152913].
• Pathway specificity: QRICH1 may have broader effects on ER stress and cellular homeostasis beyond those described here, and off-target implications warrant further study.
• Therapeutic targeting: The study does not evaluate pharmacologic inhibition or genetic manipulation of QRICH1 in vivo, limiting immediate therapeutic conclusions [source_type: workflow_recommendation][source_link: https://doi.org/10.1016/j.imbio.2025.152913].

Why this cross-domain matters, maturity, and limitations

The intersection between ER stress, viral pathogenesis, and DAMP secretion (HMGB1) is a critical cross-domain area, linking molecular cell biology with translational hepatology. While existing studies using tetracycline have largely focused on its role as an antibiotic selection marker and a probe for ribosomal function research, the reference paper extends this by exploring ER stress signaling in the context of viral infection and fibrosis. The maturity of this research lies in its integration of animal models and clinical samples, though limitations remain regarding direct therapeutic application.

Research Support Resources

For researchers aiming to model ER stress, ribosomal function, or protein secretion pathways in hepatic or other cell types, Tetracycline (SKU C6589) from APExBIO serves as a widely adopted broad-spectrum polyketide antibiotic. With its established role in inhibition of bacterial protein synthesis and as an antibiotic selection marker, tetracycline can support robust experimental workflows, particularly those requiring precise control of microbial contamination or investigation of ribosomal mechanisms [source_type: product_spec][source_link: https://www.apexbt.com/tetracycline.html]. It is highly soluble in DMSO (≥74.9 mg/mL) and should be stored at -20°C for optimal stability. For further reading on advanced applications in ER stress and fibrosis research, internal resources such as "Tetracycline as a Multifaceted Probe" provide additional perspective.